0001610717-24-000050.txt : 20240209
0001610717-24-000050.hdr.sgml : 20240209
20240209161405
ACCESSION NUMBER: 0001610717-24-000050
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240208
FILED AS OF DATE: 20240209
DATE AS OF CHANGE: 20240209
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Rosenbaum David P.
CENTRAL INDEX KEY: 0001611311
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36485
FILM NUMBER: 24615077
MAIL ADDRESS:
STREET 1: C/O ARDELYX, INC.
STREET 2: 34175 ARDENWOOD BLVD, SUITE 100
CITY: FREMONT
STATE: CA
ZIP: 94555
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ARDELYX, INC.
CENTRAL INDEX KEY: 0001437402
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 34175 ARDENWOOD BLVD.
CITY: FREMONT
STATE: CA
ZIP: 94555
BUSINESS PHONE: 510-745-7047
MAIL ADDRESS:
STREET 1: 34175 ARDENWOOD BLVD.
CITY: FREMONT
STATE: CA
ZIP: 94555
FORMER COMPANY:
FORMER CONFORMED NAME: NTERYX INC
DATE OF NAME CHANGE: 20080611
4
1
form4.xml
X0508
4
2024-02-08
0001437402
ARDELYX, INC.
ARDX
0001611311
Rosenbaum David P.
C/O ARDELYX, INC.
400 FIFTH AVENUE, SUITE 210
WALTHAM
MA
02451
true
Chief Development Officer
true
Common Stock
2024-02-08
4
S
0
15344
9.1792
D
384002
D
Common Stock
183413
I
By Wife
Common Stock
77592
I
Family Trust
Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on June 9, 2023.
This transaction was executed in multiple trades in prices ranging from $8.97 to $9.49, inclusive. The price reported in Column 4 above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
The shares are directly held by the Reporting Person's wife.
The shares are directly held by David Paul Rosenbaum and Susan Edelstein Rosenbaum, Trustees of the David Paul Rosenbaum Family Trust.
/s/ Elizabeth Grammer, Attorney-in-Fact for David Rosenbaum
2024-02-09